Sign Up
Stories
BioSyent Inc. declares dividend increase for first quarter 2024
Share
Arcutis Biotherapeutics Inducement Grant...
BioRestorative Therapies Raises $81 Mill...
BioSenic's Progress and Patent
Acquisition Progress Amid Safety Concern
Afya Limited Expands Medical Seats in Br...
Avid Bioservices Financial Turmoil
Overview
API
BioSyent Inc. declares a first quarter 2024 dividend of $0.045 per common share, an 12.5% increase from the previous quarter.
Ask a question
How does BioSyent's focus on in-licensing or acquiring innovative pharmaceutical and healthcare products impact its growth?
What are the potential benefits for BioSyent's community, specialty, and international business units?
What factors contributed to the decision to increase the dividend?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage